COLOPLAST SPON ADS EACH REPR 0. (CLPBY) Financials
CLPBY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 7.2 billion | 5.0 billion |
2023-09-30 | 6.8 billion | 4.4 billion |
2023-06-30 | 5.1 billion | 4.2 billion |
2023-03-31 | 5.2 billion | 4.1 billion |
CLPBY Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 223.8 million | ? |
2023-09-30 | 212.3 million | -141789 |
2023-06-30 | 128.3 million | -146089 |
2023-03-31 | 58.3 million | ? |
CLPBY Net Income
Date | Net Income |
---|---|
2023-12-31 | 267.5 million |
2023-09-30 | 233.2 million |
2023-06-30 | 250.4 million |
2023-03-31 | 241.7 million |
CLPBY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 135.6 million | - | 131.0 million |
2023-09-30 | 129.2 million | - | 126.8 million |
2023-06-30 | 124.9 million | - | 130.9 million |
2023-03-31 | 94.3 million | - | 127.2 million |
CLPBY Shares Outstanding
CLPBY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 40.9 million | 34.5 million | 49.6 million | 315.3 million |
2023-09-30 | 54.4 million | 32.8 million | 39.6 million | 270.1 million |
2023-06-30 | 42.5 million | 31.6 million | 38.3 million | 272.6 million |
2023-03-31 | 42.6 million | 30.6 million | 40.6 million | 275.5 million |
CLPBY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 978.0 million | 311.2 million |
2023-09-30 | 882.8 million | 296.9 million |
2023-06-30 | 892.3 million | 304.6 million |
2023-03-31 | 887.4 million | 297.8 million |
CLPBY
Price: $12.05
Dividend Yield: 1.58%
Forward Dividend Yield: 3.83%
Payout Ratio: 144.38%
Dividend Per Share: 0.46 USD
Earnings Per Share: 0.32 USD
P/E Ratio: 35.88
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 57800
Market Capitalization: 30.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 10
DGR3: 2.36%
DGR5: 4.35%